|
ZBTB8A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29709999996397E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85379999999569E-05 |
| Normal-vs-Stage2 |
2.552600E-04 |
| Normal-vs-Stage3 |
6.16640000172808E-08 |
| Normal-vs-Stage4 |
4.41170000531343E-08 |
| Stage1-vs-Stage2 |
8.428000E-01 |
| Stage1-vs-Stage3 |
1.234390E-01 |
| Stage1-vs-Stage4 |
8.755500E-03 |
| Stage2-vs-Stage3 |
3.993800E-01 |
| Stage2-vs-Stage4 |
9.474400E-02 |
| Stage3-vs-Stage4 |
3.135200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.37359999996534E-06 |
| Normal-vs-AfricanAmerican |
1.645870E-02 |
| Normal-vs-Asian |
1.57321999999516E-05 |
| Caucasian-vs-AfricanAmerican |
3.602800E-01 |
| Caucasian-vs-Asian |
8.059400E-01 |
| AfricanAmerican-vs-Asian |
3.972800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.86109999978213E-07 |
| Normal-vs-Female |
2.99240000001255E-06 |
| Male-vs-Female |
2.766400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6670399999974E-05 |
| Normal-vs-Age(41-60Yrs) |
8.63370000048214E-07 |
| Normal-vs-Age(61-80Yrs) |
7.86149999543184E-08 |
| Normal-vs-Age(81-100Yrs) |
1.526050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.288100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.601500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.904000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.527600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.514400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.144600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.196900E-04 |
| Classical-VS-Follicular |
5.708500E-02 |
| Classical-VS-Other |
4.234400E-01 |
| Classical-VS-Normal |
7.69569999999886E-05 |
| Tall-VS-Follicular |
1.135750E-01 |
| Tall-VS-Other |
4.908000E-01 |
| Tall-VS-Normal |
2.80199999869168E-08 |
| Follicular-VS-Other |
8.897200E-01 |
| Follicular-VS-Normal |
6.07759999993185E-07 |
| Other-VS-Normal |
2.856300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.75599999991039E-08 |
| Normal-vs-N1 |
1.44199999996264E-06 |
| N0-vs-N1 |
4.210600E-01 |
|
|
